摘要
目的探讨飞利浦V60无创呼吸机对慢阻肺急性加重患者的临床疗效,为慢阻肺急性加重患者的临床治疗提供理论参考。方法选取于我院进行治疗的慢阻肺急性加重患者70例,按随机数字表法平均分成对照组35例与实验组35例,对照组采取常规内科治疗,实验组在对照组的基础上予以无创呼吸机治疗;观察并分析两组患者临床疗效,利用统计学分析两组患者住院天数、使用抗生素药物时间的差异。结果治疗后,实验组总有效率37例(92.50%)明显大于对照组总有效率31例(77.50%)、抗生素使用时间及住院天数均显著短于对照组,差异有统计学意义(P<0.05)。结论无创呼吸机治疗能缓解慢阻肺急性加重患者临床症状,效果显著,还能减少抗生素的使用,提早患者康复出院时间,值得临床推广使用。
Objective To investigate the clinical efficacy of Philips V60 non-invasive ventilator in patients with acute exacerbation of chronic obstructive pulmonary disease(COPD),and to provide a theoretical reference for the clinical treatment of patients with acute exacerbations of COPD.Methods In our hospital for treatment of patients with acute exacerbation of chronic obstructive pulmonary disease in 70 cases,were randomly divided into control group of 35 cases and 35 cases in the experimental group,the control group received routine medical treatment,the experimental group was treated with non-invasive ventilator on the basis of the control group.Observation and analysis of the two groups of clinical efficacy,using statistical analysis of the two groups of patients in hospital days,the use of antibiotic drug time difference.Results After treatment,the total efficiency of experimental group was 37 cases(92.50%)was significantly higher than the control group the total efficiency of 31 cases(77.50%),antibiotic use time and hospitalization time were significantly shorter than the control group,the difference was statistically significant(<0.05).Conclusion Noninvasive ventilator therapy can relieve the clinical symptoms of acute exacerbation of chronic obstructive pulmonary disease,patients with significant effect,can reduce the use of antibiotics,early rehabilitation of patients with discharge time,is worthy of clinical use.
作者
黄朝宗
HUANG Chao-zong(Department of Internal Medicine,Third People's Hospital of Cangnan County,Cangnan 325804,Zhejiang,China)
出处
《医学信息》
2018年第1期112-113,共2页
Journal of Medical Information
关键词
无创呼吸机
慢阻肺
临床疗效
Non-invasive ventilator
Chronic obstructive pulmonary disease
Clinical efficacy
